Search filters

List of works by Aaron T Gerds

A New Style of Transplantation May Gain Points When Treating Older Patients with Acute Myeloid Leukemia

scientific article published on 14 March 2017

ACVR1/JAK1/JAK2 inhibitor momelotinib reverses transfusion dependency and suppresses hepcidin in myelofibrosis phase 2 trial

scientific article published on 01 September 2020

Adding molecular data to prognostic models can improve predictive power in treated patients with myelodysplastic syndromes.

scientific article

Albumin as a prognostic marker in myelodysplastic syndromes: still relevant after all these years

scientific article published on 25 May 2015

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia

scientific article

An international consortium proposal of uniform response criteria for myelodysplastic/myeloproliferative neoplasms (MDS/MPN) in adults

scientific article published on 26 January 2015

Analysis of distinct SF3B1 hotspot mutations in relation to clinical phenotypes and response to therapy in myeloid neoplasia

scientific article published on 03 November 2020

Association of Socioeconomic Status with Outcomes of Autologous Hematopoietic Cell Transplantation for Multiple Myeloma.

scientific article

Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphoma

scientific article published on 25 April 2016

Association of socioeconomic status with long-term outcomes in 1-year survivors of allogeneic hematopoietic cell transplantation.

scientific article published on 20 July 2015

Beyond JAK-STAT: novel therapeutic targets in Ph-negative MPN

scientific article published on 01 December 2019

Breath analysis in gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation

scientific article published on 01 September 2019

Can allogeneic hematopoietic cell transplant cure therapy-related acute leukemia?

scientific article published on 26 February 2019

Comparative Effectiveness of Busulfan and Fludarabine versus Fludarabine and 400 cGy Total Body Irradiation Conditioning Regimens for Acute Myeloid Leukemia/Myelodysplastic Syndrome.

scientific article published on 17 January 2017

Comparative effectiveness of busulfan/cyclophosphamide versus busulfan/fludarabine myeloablative conditioning for allogeneic hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome

scientific article published on 11 October 2019

Comparison of outcomes of HCT in blast phase of BCR-ABL1- MPN with de novo AML and with AML following MDS

scientific article published on 01 October 2020

Components of the revised International Prognostic Scoring System and outcome after hematopoietic cell transplantation for myelodysplastic syndrome

scientific article published in May 2013

Correction to: The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion

scientific article published on 01 January 2020

Corrigendum to "Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib" [Leukemia Res. 79 (2019) 38-44]

scientific article published on 24 April 2019

Daily Weight-Based Busulfan with Cyclophosphamide and Etoposide Produces Comparable Outcomes to Four-Times-Daily Busulfan Dosing for Lymphoma Patients Undergoing Autologous Stem Cell Transplantation.

scientific article published on 22 June 2016

Darbepoetin alfa for anemia with myelodysplastic syndrome.

scientific article published on 12 January 2015

Delayed globin synthesis leads to excess heme and the macrocytic anemia of Diamond Blackfan anemia and del(5q) myelodysplastic syndrome

scientific article

Development and Validation of a Novel Acute Myeloid Leukemia-Composite Model to Estimate Risks of Mortality

scientific article published on 7 September 2017

Effect of bone marrow CD34+cells and T-cell subsets on clinical outcomes after myeloablative allogeneic hematopoietic cell transplantation

scientific article published on 30 October 2018

Efficacy of Standard Dose R-CHOP Alternating With R-HDAC Followed by Autologous Hematopoietic Cell Transplantation as Initial Therapy of Mantle Cell Lymphoma, a Single-Institution Experience

scientific article published on 2 December 2017

Emerging importance of mutational analysis in myelodysplastic syndrome and acute myelogenous leukemia

scientific article published on January 2013

Established and novel agents for myelodysplastic syndromes

scientific article

Functional alterations in protein kinase C beta II expression in melanoma

scientific article

Genetic factors rather than blast reduction determine outcomes of allogeneic HCT in BCR-ABL-negative MPN in blast phase

scientific article published on 01 November 2020

Genomics of therapy-related myeloid neoplasms

scientific article published on 14 August 2019

GvHD-free, relapse-free survival after reduced-intensity allogeneic hematopoietic cell transplantation in older patients with myeloid malignancies

scientific article published on 10 October 2016

Haematopoietic cell transplantation for blastic plasmacytoid dendritic cell neoplasm: a North American multicentre collaborative study.

scientific article

I walk the other line: myelodysplastic/myeloproliferative neoplasm overlap syndromes

scientific article published on December 2014

Impact of cigarette smoking on survival after myeloablative allogeneic hematopoietic stem cell transplantation and contribution of invasive fungal infection.

scientific article

Influence of major histocompatibility complex class I chain-related gene A polymorphisms on cytomegalovirus disease after allogeneic hematopoietic cell transplantation

scientific article published on 24 December 2019

Initial transfusion frequency and survival in myelodysplastic syndromes: hopping onto a fast train to nowhere

scientific article published on 24 February 2014

Intergroup LEAP trial (S1612): A randomized phase 2/3 platform trial to test novel therapeutics in medically less fit older adults with acute myeloid leukemia.

scientific article

Last marrow standing: bone marrow transplantation for acquired bone marrow failure conditions.

scientific article published on December 2012

Let's talk about sex[uality]-related symptom burden in myeloproliferative neoplasms

scientific article published on 12 April 2016

Long-term survival of patients with therapy-related myeloid neoplasms after allogeneic hematopoietic cell transplantation-more than just a myth

scientific article published on 09 May 2016

Low-Dose Lenalidomide After Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation With Bortezomib as Graft-Versus-Host Disease Prophylaxis in High-Risk Multiple Myeloma

scientific article published on 08 April 2019

Mitigating Fear and Loathing in Managing Acute Myeloid Leukemia.

scientific article published on 17 March 2015

Music Therapy for Symptom Management After Autologous Stem Cell Transplantation: Results From a Randomized Study

scientific article

Mutation clonal burden and allogeneic hematopoietic cell transplantation outcomes in acute myeloid leukemia and myelodysplastic syndromes

scientific article published on 17 January 2019

Mutations in DNMT3A, U2AF1, and EZH2 identify intermediate-risk acute myeloid leukemia patients with poor outcome after CR1.

scientific article published on 10 January 2018

Myelodysplastic and myeloproliferative neoplasms: updates on the overlap syndromes.

scientific article

Myeloid/Lymphoid Neoplasms with Eosinophilia and TK Fusion Genes, Version 3.2021, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 September 2020

Myeloproliferative Neoplasms, Version 2.2017, NCCN Clinical Practice Guidelines in Oncology

scientific article

NCCN Guidelines Insights: Myeloproliferative Neoplasms, Version 2.2018.

scientific article

Outcomes after Umbilical Cord Blood Transplantation for Myelodysplastic Syndromes

scientific article

Outcomes of autologous hematopoietic cell transplantation in primary amyloidosis after bortezomib-based induction therapy

scientific article published on 04 January 2016

Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial

scientific article published on 8 March 2018

Patient-Reported Outcomes in Myelodysplastic Syndromes and MDS/MPN Overlap Syndromes: Stepping Onto the Stage with Changing Times

scientific article published on 01 October 2017

Patient-Reported Outcomes in Myelodysplastic Syndromes: the Move from Life Span to Health Span

scientific article published on 11 February 2020

Phase 1/2 trial of glasdegib in patients with primary or secondary myelofibrosis previously treated with ruxolitinib

scientific article published on 28 February 2019

Polycythemia Vera Management and Challenges in the Community Health Setting

scientific article

Pretransplantation therapy with azacitidine vs induction chemotherapy and posttransplantation outcome in patients with MDS.

scientific article

Prognostic Factors for Mortality among Day 100 Survivors after Allogeneic Hematopoietic Cell Transplantation

scientific article published on 21 January 2018

Prognostic impact of incomplete hematologic count recovery and minimal residual disease on outcome in adult acute lymphoblastic leukemia at the time of second complete response

scientific article published on 11 July 2017

Prognostic significance of pre-transplant quality of life in allogeneic hematopoietic cell transplantation recipients.

scientific article published on June 2015

Prognostic value of pre-transplant PET/CT in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation.

scientific article

Randomized phase III trial of pegfilgrastim versus filgrastim after autologus peripheral blood stem cell transplantation.

scientific article published on 4 January 2010

Real-World Outcomes of Ruxolitinib Treatment for Polycythemia Vera

scientific article published on 29 May 2020

Reduced intensity conditioning for acute myeloid leukemia using melphalan- vs busulfan-based regimens: a CIBMTR report

scientific article published on 01 July 2020

Reduced-intensity hematopoietic cell transplantation for patients with primary myelofibrosis: a cohort analysis from the center for international blood and marrow transplant research.

scientific article published on 23 October 2013

Relapse after Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndromes: Analysis of Late Relapse Using Comparative Karyotype and Chromosome Genome Array Testing

scientific article published on 4 May 2015

Reply to A. Piccardo et al, E. Hindié et al, M.C. Kreissl et al, M. Doss, J. Buscombe, R. Fisher, M. Sollini et al, M. Lichtenstein, and M. Tulchinsky et al

scientific article published on 03 May 2018

Risk of Hematologic Malignancies After Radioiodine Treatment of Well-Differentiated Thyroid Cancer

scientific article published on 18 December 2017

Risk of developing chronic myeloid neoplasms in well-differentiated thyroid cancer patients treated with radioactive iodine.

scientific article

Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera

scientific article published on 22 February 2024

Ruxolitinib Rechallenge Can Improve Constitutional Symptoms and Splenomegaly in Patients With Myelofibrosis: A Case Series

scientific article published on 28 June 2018

Scoring System Prognostic of Outcome in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.

scientific article

Social Media in Hematology in 2017: Dystopia, Utopia, or Somewhere In-between?

scientific article

Survival following allogeneic transplant in patients with myelofibrosis

scientific article published on 01 May 2020

Symptom Burden and Blood Counts in Patients With Polycythemia Vera in the United States: An Analysis From the REVEAL Study

scientific article published on 13 June 2019

Systemic Mastocytosis, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology

scientific article published on 01 December 2018

The association of histologic grade with acute graft-versus-host disease response and outcomes.

scientific article published on 4 April 2017

The graceful exit or reluctant demise of the older adult with acute myeloid leukemia

scientific article published on 29 April 2015

The prognostic value of serum erythropoietin in patients with lower-risk myelodysplastic syndromes: a review of the literature and expert opinion

scientific article published on 25 October 2019

The relationship between eligibility criteria and adverse events in randomized controlled trials of hematologic malignancies

scientific article

Therapeutic Dose Monitoring of Busulfan Is Associated with Reduced Risk of Relapse in Non-Hodgkin Lymphoma Patients Undergoing Autologous Stem Cell Transplantation

scientific article published on 11 October 2019

Time, timing, and the treatment of diffuse large B-cell lymphoma

scientific article published on 5 October 2015

Timing of allogeneic hematopoietic cell transplantation (alloHCT) for chronic myeloid leukemia (CML) patients

scientific article published on 14 July 2020

To transplant or not to transplant for adult acute myeloid leukemia: an ever-evolving decision

scientific article published on October 2012

Transplantation for myelodysplastic syndrome in the era of hypomethylating agents

scientific article published in March 2012

Treatment Patterns and Blood Counts in Patients With Polycythemia Vera Treated With Hydroxyurea in the United States: An Analysis From the REVEAL Study

scientific article published on 30 September 2019

Where to Turn for Second-Line Cytoreduction After Hydroxyurea in Polycythemia Vera?

scientific article published on 14 March 2016

Paulina is supported by:

About Paulina

Help